- Home
- WOK vs PMN Comparison
WOK vs PMN Comparison
Compare WOK & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOK
- PMN
- Stock Information
- Founded
- WOK 2002
- PMN 2004
- Country
- WOK China
- PMN Canada
- Employees
- WOK N/A
- PMN N/A
- Industry
- WOK
- PMN Pharmaceuticals and Biotechnology
- Sector
- WOK
- PMN Health Care
- Exchange
- WOK NYSE
- PMN Nasdaq
- Market Cap
- WOK 20.2M
- PMN 17.0M
- IPO Year
- WOK 2024
- PMN N/A
- Fundamental
- Price
- WOK $0.70
- PMN $0.49
- Analyst Decision
- WOK
- PMN Strong Buy
- Analyst Count
- WOK 0
- PMN 2
- Target Price
- WOK N/A
- PMN $4.50
- AVG Volume (30 Days)
- WOK 111.0K
- PMN 38.7K
- Earning Date
- WOK 02-03-2025
- PMN 08-07-2025
- Dividend Yield
- WOK N/A
- PMN N/A
- EPS Growth
- WOK N/A
- PMN N/A
- EPS
- WOK N/A
- PMN N/A
- Revenue
- WOK $11,506,440.00
- PMN N/A
- Revenue This Year
- WOK N/A
- PMN N/A
- Revenue Next Year
- WOK N/A
- PMN N/A
- P/E Ratio
- WOK N/A
- PMN N/A
- Revenue Growth
- WOK N/A
- PMN N/A
- 52 Week Low
- WOK $0.36
- PMN $0.47
- 52 Week High
- WOK $8.45
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- WOK N/A
- PMN 43.83
- Support Level
- WOK N/A
- PMN $0.48
- Resistance Level
- WOK N/A
- PMN $0.53
- Average True Range (ATR)
- WOK 0.00
- PMN 0.03
- MACD
- WOK 0.00
- PMN 0.00
- Stochastic Oscillator
- WOK 0.00
- PMN 21.29
About WOK WORK MEDICAL TECHNOLOGY GROUP LTD
WORK Medical Technology Group Ltd is engaged in manufacturing and selling medical consumables through its wholly owned subsidiaries in the People's Republic of China. The Company's main products include medical face masks, tourniquets, airways, breathing circuits, intubation accessories, anesthesia kits, oxygen masks, suction sets, laryngoscope blades, KN95 masks, and other disposable medical devices, as well as medical equipment.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.